CFSAN 1999 "report card"
This article was originally published in The Tan Sheet
Executive Summary
FDA center completed "nearly 90%" of its "A" list goals in 1999, handling 73 of the 83 activities included in its yearly strategic plan. Among the achievements listed are the publication of a proposed rule on nutrient content/health claims based on authoritative statements for dietary supplements, holding five stakeholder meetings to address various supplement issues, publishing a guidance defining "significant scientific agreement" and developing a 10-year strategy for "achieving effective regulation of dietary supplements." Among the 10 unaccomplished activities, which "will be carried over to 2000," are "Ephedra" and "Infant Formula - Final Rules on GMPs and Quality Factors." CFSAN will announce its 2000 program priorities the week of Feb. 7
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning